Assenagon Asset Management’s Amicus Therapeutics FOLD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.2M | Buy |
3,533,854
+3,057,072
| +641% | +$17.5M | 0.03% | 325 |
|
|
2025
Q1 | $3.89M | Hold |
476,782
| – | – | 0.01% | 565 |
|
|
2024
Q4 | $4.49M | Sell |
476,782
-1,561,114
| -77% | -$14.7M | 0.01% | 688 |
|
|
2024
Q3 | $21.8M | Buy |
2,037,896
+1,192,489
| +141% | +$12.7M | 0.04% | 304 |
|
|
2024
Q2 | $8.39M | Buy |
+845,407
| New | +$8.39M | 0.02% | 458 |
|
|
2020
Q3 | – | Sell |
-1,583,568
| Closed | -$23.9M | – | 1162 |
|
|
2020
Q2 | $23.9M | Buy |
1,583,568
+301,513
| +24% | +$4.55M | 0.15% | 78 |
|
|
2020
Q1 | $11.8M | Buy |
1,282,055
+553,971
| +76% | +$5.12M | 0.09% | 135 |
|
|
2019
Q4 | $7.09M | Buy |
728,084
+487,774
| +203% | +$4.75M | 0.04% | 172 |
|
|
2019
Q3 | $1.93M | Buy |
+240,310
| New | +$1.93M | 0.01% | 372 |
|
|
2019
Q2 | – | Sell |
-2,872,378
| Closed | -$39.1M | – | 1007 |
|
|
2019
Q1 | $39.1M | Buy |
2,872,378
+2,101,069
| +272% | +$28.6M | 0.37% | 45 |
|
|
2018
Q4 | $7.39M | Buy |
+771,309
| New | +$7.39M | 0.08% | 141 |
|